See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
0
0
$0.00
$0.00
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
No Insider Transactions found for Vistagen Therapeutics, Inc.
View older insider trading records reported to the SEC to research long-term buying and selling trends.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Aug 07, 2023 COMMODORE CAPITAL LP |
COMMODORE CAPITAL LP
|
Buy |
775,756 | $23.15 | 775,756 $23.15 $17,961,079 |
Aug 18, 2022 GIN JERRY B |
GIN JERRY B
|
Buy |
100,000 | $0.18 | 100,000 $0.18 $17,870 |
Aug 18, 2022 GIN JERRY B |
GIN JERRY B
|
Buy |
100,000 | $0.18 | 100,000 $0.18 $17,870 |
Aug 17, 2022 Singh Shawn |
Singh Shawn
CEO
|
Buy |
600,000 | $0.17 | 600,000 $0.17 $103,200 |
Aug 17, 2022 Adler Reid G. |
Adler Reid G.
CLO
|
Buy |
300,000 | $0.17 | 300,000 $0.17 $50,910 |
Jul 12, 2022 Venrock Healthcare Capital Partners II, L.P. |
Venrock Healthcare Capital Partners II, L.P.
|
Sell |
60,000 | $0.89 | 60,000 $0.89 $53,400 |
Sep 07, 2021 DOTSON JERROLD DUANE |
DOTSON JERROLD DUANE
VP, CFO and Secretary
|
Sell |
30,000 | $3.13 | 30,000 $3.13 $93,750 |
Aug 17, 2021 SNODGRASS H. RALPH |
SNODGRASS H. RALPH
PRES./CHIEF SCIENTIFIC OFFICER
|
Buy |
3,750 | $2.73 | 3,750 $2.73 $10,238 |
Aug 21, 2020 SAXE JON S |
SAXE JON S
|
Buy |
30,000 | $0.69 | 30,000 $0.69 $20,700 |
Nov 20, 2019 SNODGRASS H. RALPH |
SNODGRASS H. RALPH
PRES./CHIEF SCIENTIFIC OFFICER
|
Buy |
15,000 | $0.34 | 15,000 $0.34 $5,100 |
Mar 14, 2019 SAXE JON S |
SAXE JON S
|
Buy |
7,920 | $1.27 | 7,920 $1.27 $10,086 |
Mar 13, 2019 SAXE JON S |
SAXE JON S
|
Buy |
12,080 | $1.26 | 12,080 $1.26 $15,201 |
TOP